^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Ocrevus (ocrelizumab)

i
Other names: PRO 70769, R 1594, RG1594, rhuMab 2H7, PRO70769, OCR, RO4964913, PRO-70769, R1594, RO-4964913, RG 1594, RO 4964913, R-1594, RG-1594
Associations
Trials
Company:
Biogen, Roche
Drug class:
CD20 inhibitor
Related drugs:
Associations
Trials